Marked thrombocytosis and dysmegakaryopoiesis in acute myeloid leukemia with t(2;3)(p22;q26.2) and EVI1 rearrangement

Ann Hematol. 2013 Dec;92(12):1713-5. doi: 10.1007/s00277-013-1750-0. Epub 2013 Apr 19.

Authors

Katsuya Yamamoto¹, Atsuo Okamura, Yukinari Sanada, Kimikazu Yakushijin, Hiroshi Matsuoka, Hironobu Minami

Affiliation

¹ Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan, kyamamo@med.kobe-u.ac.jp.

PMID: 23604431
DOI: 10.1007/s00277-013-1750-0

No abstract available

Publication types

Case Reports
Letter

MeSH terms

DNA-Binding Proteins / genetics*
Gene Rearrangement / genetics*
Humans
Leukemia, Myeloid, Acute / complications
Leukemia, Myeloid, Acute / diagnosis
Leukemia, Myeloid, Acute / genetics*
MDS1 and EVI1 Complex Locus Protein
Male
Middle Aged
Proto-Oncogenes / genetics*
Thrombocytosis / complications
Thrombocytosis / diagnosis
Thrombocytosis / genetics*
Thrombopoiesis / genetics*
Transcription Factors / genetics*
Translocation, Genetic / genetics*

Substances

DNA-Binding Proteins
MDS1 and EVI1 Complex Locus Protein
MECOM protein, human
Transcription Factors